同一个风险基因,为什么在夜班下是保护、在月光下未必

Written by

in

Language

Evidence level: B

MTNR1B 的风险等位在人造光照(夜班)下是缓冲器,但人造光和月光是两片”不相似的环境”——按基因×环境交互的普遍规律,方向未必跟过去。

正文

前一篇问的是”基因型×月相”这个交互有没有。这一篇问更难的一层:如果真有,方向是哪一边。

一、G 等位到底是好是坏,已经开始分裂

MTNR1B 的 rs10830963(G 等位)编码褪黑素 MT2 受体上一个常见变异,生理后果很具体:G 携带者的褪黑素升高时长比非携带者多 41 分钟,褪黑素终止相位平均延后 1.37 小时(PMID 26868293)——夜里褪黑素信号更长、更晚才关掉。

那它是好是坏?在代谢线上是明确的”坏”:337,083 人的 UK Biobank 分析里,CG 携带者 2 型糖尿病风险 1.10 倍、GG 1.21 倍(PMID 31623012)。但在光照扰动这条线上,它突然变成了”好”的。

二、夜班证据:G 是缓冲器

这是本文最重要的对照。UK Biobank 242,194 人、12 年随访的卒中分析发现:夜班只在 CC 纯合子里把卒中风险推到 HR 1.23,GC/GG 携带者完全没有这个风险,交互 P=0.010(PMID 35411403)。同一人群另一结局——前列腺癌,133,416 名男性,交互 P=0.009,夜班者里 GC 对 CC 是 HR 0.69、GG 对 CC 是 HR 0.33(PMID 35064058)。两个独立结局、同一方向:G 等位在人造光照扰动下是缓冲器,不是放大器。作者的解释也顺:夜班把外在明暗循环整个翻了过来,而 G 携带者的内源时钟本来就偏晚,外部反转反而与内部节奏对上了。

三、可方向并不一致

换个分析、换个扰动量,方向会翻。216,702 人的 UK Biobank 报告(PMID 35467761)显示 rs10830963 与乳腺癌、前列腺癌均不独立相关(Ptrend = 0.103 / 0.281),但一分层,晚型女性的乳腺癌风险升高只出现在 G 等位携带者里(Ptrend = 0.015)——这里 G 是放大器。另一个 337,083 人分析(PMID 31623012)里,”晚型→风险升高”只出现在 CC 与 CG 组,GG 组消失;而最初那篇生理学论文(PMID 26868293)发现糖尿病风险升高在早起的人里更明显。更关键的是有一份大样本直接说”没有交互”:189,488 人(PMID 31757795)报告 rs10830963 与 2 型糖尿病的关联完全没被轮班工作修改,晨昏偏好那项只有边际证据,且扩展到全体受试者、改用加速度计客观睡眠中点后就不成立。

于是现实是:同一位点、同一人群、同一框架,方向随结局、随扰动量定义、随分层方式而变。

四、为什么方向可能反转:酵母给的骨架

这不是人类遗传学独有的混乱。Wei 与 Zhang 用 1005 个酵母分离体、47 种环境做全基因组 g×eQTL 扫描(PMID 27903611),得到两条规律:① 多数交互位点在两种环境里方向一致,但某环境中效应越大,另一环境出现”拮抗”(方向相反)的概率越高;② 拮抗位点显著富集在性质不相似的环境中。更早的酵母表达研究(PMID 18416601)补上机制:顺式变异跨环境方向稳定,反式变异高度依赖环境、经常在两种条件下朝向相反;实验若不控制条件,这些相反效应会互相抵消,最后显示”没关系”。

搬到人和月亮上就清楚了:月相(0.1-0.3 lux,天然、微弱、慢性)与夜班(人造、强烈、急性)是两片不相似的环境。G 等位在夜班下的缓冲,没有理由被直接搬给月相——按酵母的规律,环境越不相似,方向反转概率越高,”翻转”和”没交互”都是合理结局。

五、难点不是假设,是功效

Duncan 与 Keller 审查精神病遗传学基因×环境交互研究的最初十年、103 项研究(PMID 21890791):新发现 96% 阳性,复制尝试只有 27% 阳性;按观测样本量算功效,即便假设交互效应量大于已知的任何主效应,多数研究仍功效不足;按功效与先验估计的假发现率超过 97%。根子在数学上很朴素——交互项是”基因×环境”的乘积,在非实验人群里方差天然很小,方差小就检不出。作者还纠正了一个流行误解:乘积项与主效应项的相关性不影响交互检验的功效。

这对”月相×MTNR1B”是硬约束。月相主效应本就只剩十几分钟量级,交互项只会更小,基因型又无法按极端分组抽样。要检验方向,样本量与记录时长必须按”方向可检出”而非按主效应设计,且方向假设必须预注册——否则看到什么都能解释成翻转。同时个体光敏感度差异极大:55 人的个体化剂量-反应显示 50% 抑制有效剂量从 6 lux 到 350 lux、横跨一个数量级,变异系数 26%(PMID 31138694);褪黑素抑制起效阈值约 1.5 melanopic lux、饱和在 305(PMID 30697806)。月照确实落在低剂量敏感段——这既是”可能有作用”的理由,也是”极难稳定检出”的理由。

六、对易学的意义

命理里有个基本规矩:同一个字,在不同的运里角色可以完全反过来——”用神”随大运流年而变,不存在天生就好的字。G 等位在这里扮演的正是这个角色:在人造光照下是缓冲器,在天然光照下该是缓冲还是放大,没有人测过。而酵母的规律说明这不是含糊其辞,而是有具体预测的:扰动源越不相似,方向反转概率越高。

这也正是”天人相应”最容易被讲错的地方。它讲的不是”天好你就好”,而是同一个天、不同的人、接法不同。月亮对所有人一样圆,但”顺”与”逆”是相对于各自的节奏说的——所以正确的问法从来不是”月亮有害吗”,而是”对我这条作息线,月亮是推力还是阻力”。

证据与局限

已验证: MTNR1B rs10830963 G 等位独立调节褪黑素分泌动力学(+41 分钟、终止相位延迟 1.37 小时,PMID 26868293)并升高 2 型糖尿病风险(PMID 31623012);夜班×rs10830963 交互在两个独立结局中方向一致地显示 G 等位缓冲(卒中 P=0.010、PMID 35411403;前列腺癌 P=0.009、PMID 35064058);分层分析中出现方向相反的证据(乳腺癌晚型 Ptrend=0.015、PMID 35467761);同一交互在一份 189,488 人样本中未复现(PMID 31757795);酵母 g×eQTL 的拮抗方向富集于不相似环境(PMID 27903611)、反式变异跨条件方向常相反且可相互抵消(PMID 18416601);cG×E 首十年 96% 新发现阳性对 27% 复制阳性、假发现率 >97%(PMID 21890791);个体光敏感度 ED50 跨 6-350 lux(PMID 31138694);褪黑素抑制起效约 1.5 melanopic lux(PMID 30697806)。

部分验证: “月相→ipRGC→SCN→松果体→褪黑素→MT2→睡眠”链条逐环有证据,但整链在真实月照(0.1-0.3 lux)下能否驱动可测的褪黑素变化缺少直接测量;月照落于低剂量敏感段属换算推断,非实测抑制量。

待验证: 月相×MTNR1B 交互的方向——G 等位在天然光照下是放大还是缓冲,无任何研究直接检验;该方向是否与夜班下的缓冲方向相反;交互方向是否随扰动源强度与光谱比例系统性变化;在按方向检出设计的样本量下,交互能效是否足够。

相关阅读

证据等级: B
参考文献: PMID 26868293, PMID 31623012, PMID 35411403, PMID 35064058, PMID 35467761, PMID 31757795, PMID 27903611, PMID 18416601, PMID 21890791, PMID 31138694, PMID 30697806


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Why Does the Same Risk Gene Act as a Protector Under Night Shifts but Not Under Moonlight?

Evidence level: B

The risk allele of MTNR1B acts as a buffer under artificial light (night shifts), yet artificial light and moonlight represent two “dissimilar environments.” According to the general law of gene-by-environment interactions, the direction need not mirror the past.

Main Text

The previous inquiry asked whether a “genotype × lunar phase” interaction exists. This piece addresses the more difficult layer: if it exists, which direction does it take?

I. The “Good” or “Bad” Nature of the G Allele Is Already Splitting

The rs10830963 (G allele) of MTNR1B encodes a common variant at the melatonin MT2 receptor. The physiological consequence is specific: G carriers experience a 41-minute longer duration of elevated melatonin and an average delay of 1.37 hours in the termination phase compared to non-carriers (PMID 26868293)—meaning the nocturnal melatonin signal is longer and turns off later.

So, is it good or bad? On the metabolic line, it is clearly “bad”: in a UK Biobank analysis of 337,083 individuals, CG carriers had a 1.10-fold risk and GG carriers a 1.21-fold risk for type 2 diabetes (PMID 31623012). However, on the line of light perturbation, it suddenly becomes “good.”

II. Night Shift Evidence: G Acts as a Buffer

This is the most critical comparison in this text. A stroke analysis of 242,194 individuals from the UK Biobank with 12 years of follow-up found that night shifts only elevated stroke risk to HR 1.23 in CC homozygotes, while GC/GG carriers showed no such risk, with an interaction P=0.010 (PMID 35411403). In the same population for a different outcome—prostate cancer, in 133,416 males—the interaction P=0.009; among night shift workers, GC showed HR 0.69 relative to CC and GG showed HR 0.33 relative to CC (PMID 35064058). Two independent outcomes, same direction: the G allele acts as a buffer under artificial light perturbation, not an amplifier. The authors’ explanation aligns: night shifts flip the external light-dark cycle entirely, while G carriers already have an endogenous clock biased late; the external reversal thus aligns with their internal rhythm.

III. Direction Is Not Consistent Across Analyses

Change the analysis, change the perturbation magnitude, and the direction flips. A UK Biobank report of 216,702 individuals (PMID 35467761) showed that rs10830963 was not independently associated with breast cancer or prostate cancer (Ptrend = 0.103 / 0.281), but upon stratification, breast cancer risk elevation in late-type women appeared only in G allele carriers (Ptrend = 0.015)—here, G acts as an amplifier. In another analysis of 337,083 individuals (PMID 31623012), “late-type → risk elevation” appeared only in CC and CG groups, disappearing in the GG group; conversely, the initial physiological paper (PMID 26868293) found that diabetes risk elevation was more pronounced in early risers. More critically, one large sample directly states “no interaction”: an analysis of 189,488 individuals (PMID 31757795) reported that the association between rs10830963 and type 2 diabetes was not modified by shift work, with circadian preference showing only marginal evidence, and the finding failed when extended to all subjects or when using accelerometers for objective sleep timing.

Thus, reality is: at the same locus, same population, same framework, the direction varies by outcome, by definition of perturbation magnitude, and by stratification method.

IV. Why Direction Might Reverse: A Skeleton from Yeast

This is not chaos unique to human genetics. Wei and Zhang used 1,005 yeast isolates and 47 environmental conditions for a whole-genome g×eQTL scan (PMID 27903611), deriving two rules: ① Most interaction loci show consistent direction across environments, but the probability of “antagonism” (opposite direction) increases in the other environment where the effect is larger; ② Antagonistic loci are significantly enriched in dissimilar environments. Earlier yeast expression studies (PMID 18416601) supplemented the mechanism: cis-variants show stable direction across environments, while trans-variants are highly dependent on the environment and often orient oppositely under two conditions; if experimental conditions are not controlled, these opposing effects cancel each other out, finally displaying “no relationship.”

Applying this to humans and the moon clarifies the situation: lunar phase (0.1–0.3 lux, natural, weak, chronic) and night shifts (artificial, strong, acute) are two dissimilar environments. The buffering effect of the G allele under night shifts has no reason to be directly transposed to lunar phase—according to yeast rules, the less similar the environments, the higher the probability of direction reversal; both “flip” and “no interaction” are reasonable outcomes.

V. The Difficulty Is Not Assumption, But Power

Duncan and Keller reviewed the first decade of gene-by-environment interaction studies in psychiatric genetics, covering 103 studies (PMID 21890791): new discoveries showed 96% positivity, while replication attempts yielded only 27% positivity; by observed sample size calculations, statistical power—even assuming the interaction effect size is larger than any known main effect—is insufficient for most studies; by power and prior estimates, the false discovery rate exceeds 97%. The root is mathematically simple—the interaction term is a “gene × environment” product, which naturally has very small variance in non-experimental populations; small variance makes detection difficult. The authors also corrected a popular misconception: the correlation between product terms and main effect terms does not affect the power of interaction testing.

This imposes a hard constraint on “lunar phase × MTNR1B.” The main effect of lunar phase is already only on the order of tens of minutes; the interaction term would be even smaller, and genotypes cannot be sampled by extreme grouping. To test direction, sample size and recording duration must be designed based on “detectability of direction” rather than main effects, and the directional hypothesis must be preregistered—otherwise, anything seen can be explained as a flip. Furthermore, individual light sensitivity varies greatly: personalized dose-response data from 55 individuals showed that the effective dose (ED50) for inhibition varied from 6 lux to 350 lux, spanning an order of magnitude, with a coefficient of variation of 26% (PMID 31138694); the threshold for melatonin inhibition onset is approximately 1.5 melanopic lux, saturating at 305 (PMID 30697806). Lunar illumination indeed falls within the low-dose sensitive range—this is both a reason for “possible effect” and a reason for “extreme difficulty in stable detection.”

VI. Implications for Yijing Studies

In divination theory, there is a basic rule: the same character can have roles that are completely reversed in different fortunes—”useful gods” change with major cycles and annual flows; no character is inherently good. The G allele plays precisely this role here: it acts as a buffer under artificial light, but whether it should be a buffer or amplifier under natural light has never been measured. Meanwhile, yeast rules indicate this is not vague rhetoric but carries specific predictions: the less similar the perturbation source, the higher the probability of direction reversal.

This is also precisely where “harmony between heaven and man” is most easily misunderstood. It does not mean “if the sky is good, you are good,” but rather the same sky, different people, different connections. The moon looks round to everyone, but “following” versus “opposing” is relative to one’s own rhythm—so the correct question is never “is the moon harmful?” but rather “for my schedule line, is the moon a push or a resistance?”

Evidence and Limitations

Verified: MTNR1B rs10830963 G allele independently regulates melatonin secretion dynamics (+41 minutes, termination phase delay 1.37 hours, PMID 26868293) and increases type 2 diabetes risk (PMID 31623012); night shift × rs10830963 interaction consistently shows G allele buffering across two independent outcomes (stroke P=0.010, PMID 35411403; prostate cancer P=0.009, PMID 35064058); stratified analysis reveals evidence of opposite direction (breast cancer late-type Ptrend=0.015, PMID 35467761); the same interaction was not replicated in one sample of 189,488 individuals (PMID 31757795); antagonistic direction in yeast g×eQTL is enriched in dissimilar environments (PMID 27903611), and trans-variants often show opposite directions across conditions which can cancel each other out (PMID 18416601); in the first decade of cG×E studies, 96% new discoveries were positive versus 27% replication positivity, with false discovery rate >97% (PMID 21890791); individual light sensitivity ED50 spans 6–350 lux (PMID 31138694); melatonin inhibition onset is approximately 1.5 melanopic lux (PMID 30697806).

Partially Verified: The chain “lunar phase → ipRGC → SCN → pineal gland → melatonin → MT2 → sleep” has evidence at each link, but whether the entire chain drives measurable melatonin changes under real moonlight (0.1–0.3 lux) lacks direct measurement; lunar illumination falling into the low-dose sensitive range is a conversion inference, not measured inhibition levels.

To Be Verified: The direction of the lunar phase × MTNR1B interaction—whether the G allele acts as an amplifier or buffer under natural light, no study has directly tested this; whether this direction is opposite to the buffering direction under night shifts; whether interaction direction systematically varies with perturbation intensity and spectral ratios; whether interaction power is sufficient under sample sizes designed for direction detection.

Related Reading

Evidence Level: B
References: PMID 26868293, PMID 31623012, PMID 35411403, PMID 35064058, PMID 35467761, PMID 31757795, PMID 27903611, PMID 18416601, PMID 21890791, PMID 31138694, PMID 30697806


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *